Glaxosmithkline | GSK - Stock

Aktienkurs
52.10
Täglich Wechseln
-7.02 -11.87%
Monatlich
-14.38%
Jährlich
31.73%
Q1 Prognose
52.28




Stock Veränderung Datum
AbbVie USD 4.95B 13M 2025-12
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
Aurora Cannabis CAD 221.96M 6.3M 2025-09
Bausch Health Companies USD 1.6B 57M 2025-09
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Canopy Growth CAD 102.37M 8.55M 2025-09
Corcept Therapeutics USD 12.87M 519K 2025-12
Drreddys Laboratories INR 79.01B 3.41B 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
GlaxoSmithKline GBP 6.12B 46M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
J&J USD 14.19B 45M 2025-12
Merck USD 6.44B 157M 2025-09
Novartis USD 6.42B 114M 2025-09
Pacira USD 152.86M 4.82M 2025-12
Perrigo USD 1.15B 78M 2025-12
Pfizer USD 11.47B 201M 2025-09
Phibro Animal Health USD 517.35M 45.57M 2025-12
Prestige Brands USD 163.59M 4.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Supernus Pharmaceuticals USD 107.1M 63.08M 2025-09
Takeda JPY 1.41T 107.71B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Zoetis USD 2.43B 35M 2025-12